Taking statins every day to control cholesterol could soon become a thing of the past and be replaced instead by twice-yearly jabs.
Spectacular results from trials of an injectable drug called inclisiran show that it can slash 'bad' LDL cholesterol levels by more than 50 per cent after just two weeks, and that after the jab, levels stay stable for six months.